Muller & Phipps (India) Limited (BOM:501477)

Market Cap	132.50M -32.7%
Revenue (ttm)	69.08M +11.5%
Net Income	-475.00K
EPS	-0.76
Shares Out	625.00K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14
Open	212.00
Previous Close	223.00
Day's Range	212.00 - 212.00
52-Week Range	188.10 - 377.00
Beta	-0.75
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Muller & Phipps (India)

Muller & Phipps (India) Limited markets and distributes over the counter medical preparation and home care products in India. The company sells medicated dental cream, gel, and gum astringent products under the Cavisan brand; skincare products under the Cavidine and Nixoderm brand name; cosmetics and toiletries, medicated preparations, and food products. It markets its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. T...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1917
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 501477

Financial Performance

In fiscal year 2026, Muller & Phipps (India)'s revenue was 69.08 million, an increase of 11.51% compared to the previous year's 61.94 million. Losses were -475,000, -93.72% less than in 2025.